Jonathan M. Kurie
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, OncologyGoogle:
"Jonathan Kurie"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tan X, Xiao GY, Wang S, et al. (2023) EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. The Journal of Clinical Investigation |
| Chen Z, Zheng L, Chen Y, et al. (2022) Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis. Cancer Biology & Therapy. 23: 265-280 |
| Kim EJ, Kim JS, Lee S, et al. (2022) ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells. Cancer Letters. 533: 215601 |
| Wilson AN, Chen B, Liu X, et al. (2022) A Method for Orthotopic Transplantation of Lung Cancer in Mice. Methods in Molecular Biology (Clifton, N.J.). 2374: 231-242 |
| Tan X, Banerjee P, Liu X, et al. (2021) Transcriptional control of a collagen deposition and adhesion process that promotes lung adenocarcinoma growth and metastasis. Jci Insight |
| Tang M, Abbas HA, Negrao MV, et al. (2021) The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nature Communications. 12: 7081 |
| Bota-Rabassedas N, Banerjee P, Niu Y, et al. (2021) Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity. Cell Reports. 35: 109009 |
| Liu X, Lu Y, Chen Z, et al. (2020) The Ubiquitin Specific Protease USP18 Promotes Lipolysis, Fatty Acid Oxidation and Lung Cancer Growth. Molecular Cancer Research : McR |
| Kawakami M, Mustachio LM, Chen Y, et al. (2020) A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis and Metastasis in Aneuploid Cancers. Molecular Cancer Therapeutics |
| Tan X, Shi L, Banerjee P, et al. (2020) A pro-tumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. The Journal of Clinical Investigation |